We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Efficacy of dupilumab in real-life settings: a STROBE study

    Background

    Dupilumab, a monoclonal antibody targeting IL-4 and IL-13, has demonstrated its efficacy in several clinical trials. However, to date,...

    A. Gal, R. Gravier-Dumonceau, ... J. Michel in European Archives of Oto-Rhino-Laryngology
    Article 18 March 2024
  2. Real life evaluation of AlphaMissense predictions in hematological malignancies

    High-throughput sequencing plays a pivotal role in hematological malignancy diagnostics, but interpreting missense mutations remains challenging. In...

    Kaddour Chabane, Carole Charlot, ... Pierre Sujobert in Leukemia
    Article 22 December 2023
  3. Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study)

    Data about the impact of Belimumab on corticosteroid sparing in real life are scarce. To assess the corticosteroid-sparing effect among patients with...

    Marie Jaïs, Pascal Roblot, ... Amandine Perier in Rheumatology International
    Article 30 April 2024
  4. Real-life experiences with galcanezumab and predictors for treatment response in Turkey

    Background

    The complexity of clinical practice extends far beyond the controlled settings of trials, and there is a need for real-world studies aimed...

    Pınar Yalinay Dikmen, Betül Baykan, ... Mustafa Ertaş in BMC Neurology
    Article Open access 23 November 2023
  5. Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up

    Objective

    Pasireotide LAR (PAS-LAR) was released in Italy in 2017 to treat acromegaly patients resistant to SRLs (Somatostatin Receptors Ligands). The...

    C. Urbani, F. Dassie, ... F. Bogazzi in Journal of Endocrinological Investigation
    Article Open access 20 January 2024
  6. Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience

    Introduction

    Tirbanibulin 1% ointment has been licensed to treat non-hyperkeratotic actinic keratosis (AKs) on the face and scalp in adults to ensure...

    Federica Li Pomi, Lucia Peterle, ... Francesco Borgia in Dermatology and Therapy
    Article Open access 14 May 2024
  7. Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center

    Purpose

    Pasireotide is a novel therapeutic option for patients with acromegaly resistant to first-generation somatostatin receptor ligands. To date,...

    R. Pirchio, R. S. Auriemma, ... A. Colao in Journal of Endocrinological Investigation
    Article Open access 26 March 2024
  8. Predictors of change in asthma-related quality of life: a longitudinal real-life study in adult asthmatics

    Purpose

    Asthma negatively impacts health-related quality of life (HRQL). The objective is to investigate the longitudinal relationship between HRQL in...

    Gilles Louis, Benoit Pétré, ... Renaud Louis in Quality of Life Research
    Article Open access 03 January 2023
  9. Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

    Background

    The availability of multiple treatments for type 1 Gaucher disease increases the need for real-life studies to evaluate treatment efficacy...

    Irene Serrano-Gonzalo, Laura López de Frutos, ... Pilar Giraldo in Orphanet Journal of Rare Diseases
    Article Open access 15 December 2023
  10. Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature

    Introduction

    The recent approval of Dupilumab has profoundly revolutionized the management of patients affected by severe and recalcitrant Chronic...

    Marella Reale, Giuseppe Licci, ... Oreste Gallo in European Archives of Oto-Rhino-Laryngology
    Article 19 May 2024
  11. Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience

    Background

    Daratumumab, an anti-CD38 monoclonal antibody, is used for treatment of multiple myeloma (MM) and light chain amyloidosis at an intravenous...

    Danilo De Novellis, Raffaele Fontana, ... Carmine Selleri in Targeted Oncology
    Article Open access 25 September 2023
  12. A physiologically-based digital twin for alcohol consumption—predicting real-life drinking responses and long-term plasma PEth

    Alcohol consumption is associated with a wide variety of preventable health complications and is a major risk factor for all-cause mortality in the...

    Henrik Podéus, Christian Simonsson, ... Gunnar Cedersund in npj Digital Medicine
    Article Open access 03 May 2024
  13. Real-life outcomes in biotypes of psychotic disorders based on neurocognitive performance

    Aiming at discerning potential biotypes within the psychotic syndrome, we have recently reported the possible existence of two clusters or biotypes...

    Vicente Molina, Inés Fernández-Linsenbarth, ... Javier Sanz-Fuentenebro in European Archives of Psychiatry and Clinical Neuroscience
    Article Open access 22 November 2022
  14. Real-life management of patients with mild cognitive impairment: an Italian survey

    Background

    Mild cognitive impairment (MCI) is a syndrome with heterogeneous underlying causes and different rates of disease progression, whose...

    Laura Bonanni, Annachiara Cagnin, ... Innocenzo Rainero in Neurological Sciences
    Article Open access 25 March 2024
  15. Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands

    Introduction

    Psoriasis is a chronic inflammatory condition that can significantly impact the quality of life (QoL), regardless of the level of skin...

    Juul M. P. A. van den Reek, Robert J. T. van der Leest, ... Elke M. G. J. de Jong in Advances in Therapy
    Article 24 February 2024
  16. The use of biologics in patients suffering from chronic rhinosinusitis with nasal polyps – a 4-year real life observation

    Purpose

    Antibody therapy for chronic rhinosinusitis with nasal polyps (CRSwNP) has been established in Germany since 2019. With limited long-term data...

    Hanna Frankenberger, Robert Wiebringhaus, ... Clemens Stihl in European Archives of Oto-Rhino-Laryngology
    Article Open access 08 July 2024
  17. Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults

    Introduction

    The efficacy and safety of upadacitinib in atopic dermatitis have been defined in clinical trials, but long-term real-life experience,...

    Axel De Greef, Pierre-Dominique Ghislain, ... Marie Baeck in Advances in Therapy
    Article Open access 21 March 2023
  18. Impact of a digital web-based asthma platform, a real-life study

    Background

    Digital health technology (DHT) is a growing area in the treatment of chronic diseases. Study results on DHT’s effect on asthma control...

    Emma M. Genberg, Hilkka T. Viitanen, ... Paula M. Kauppi in BMC Pulmonary Medicine
    Article Open access 12 May 2023
  19. Long-term real-life outcomes of the Clareon® hydrophobic intraocular lens: the Clarte study in 191 eyes

    Background

    To describe and analyze the real-life refractive, functional and safety outcomes of the Clareon® intraocular lens (IOL) after 3 years.

    ...
    Hugo Bouvarel, Emilie Agard, ... Corinne Dot in BMC Ophthalmology
    Article Open access 26 March 2024
  20. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

    Health technology assessment (HTA) can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are...

    Dean A. Regier, Samantha Pollard, ... Deirdre Weymann in npj Precision Oncology
    Article Open access 25 October 2022
Did you find what you were looking for? Share feedback.